Health Condition 1: J309- Allergic rhinitis, unspecified
Conditions
Interventions
Intervention1: ORAL UNANI FORMULATION(JOSHANDA) AND ROGHAN BANAFSHA AS QATUR-I-ANF(NASAL DROP): ORAL UNANI FORMULATION(JOSHANDA) WILL BE GIVEN 50 ML TWICE A DAY AND QATUR-I-ANF(NASAL DROP) WILL BE GIV
Sponsors
State Unani Medical College and HAHRDM Hospital Himmatganj Prayagraj
Eligibility
Inclusion criteria
Inclusion criteria: Symptoms persisted for more than 4 days per week or more than 4 weeks per year and at least one of the following rhinitis-associated conditions: nasal congestion, rhinorrhea sneezing and nasal itching. Patients who will give consent and able to do follow up
Exclusion criteria
Exclusion criteria: Patients below 18 and above 60 years. Patients suffering from systemic illness like Hypertension, Diabetes Mellitus, Malignancy,Liver or kidney dysfunction. Patients suffering from congenital nasal abnormalities like nasal dermoid cysts, Deviated Nasal Septum, Atrophic rhinitis, Sinusitis, Hypertrophic turbinates, Adenoidal hypertrophy, foreign bodies. Patients had received systematically administered corticosteroids, antihistamines, decongestants or CAM therapy within 02 weeks prior to enrolment. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum IgE Symptom Severity ScoreTimepoint: 7th,14th,21st day from baseline | — |
Secondary
| Measure | Time frame |
|---|---|
| Japanese Rhino-conjunctivitis Quality of Life QuestionnaireTimepoint: 7th,14th,21st,28th day from baseline | — |
Countries
India
Contacts
Public ContactNurain Siddiqi
State Unani Medical College Himmatganj Prayagraj Uttar Pradesh 211016
Outcome results
None listed